Skip to content

Goed Hulpmiddelen

Active
Cooperative companyfounded 2003active for 23 yearsAntwerpsesteenweg 263, 2800 Mechelen, BelgiumKBO/BCE: BE 0860.548.465
Summary

Goed Hulpmiddelen has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7.9m and a net result of -€19.3m. Equity is shrinking by about 20% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 21% of 4,937 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741
Largest employer in Mechelen, Wholesale and retail trade sector38 sites
Size
€87.4mturnover 2025
Staff
541.6 FTE
Equity
€7.9m
Loss
-€19.3m
Standalone figures, without subsidiaries
Financial health
65 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.2%
Structure
Board
11 members
Holdings
2
Auditor: Deloitte BedrijfsrevisorenAccounts 29 days early
Why 65raises riskLoss of €19.3m, the second in a row (financial year 2025)Equity €7.9m (10.2% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: turnover €87.4m, 541.6 FTE, total assets €77.2m, files consolidated accountsShow the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 47% of its sector peers (NACE 47, large)
Financial strength · tick = 2024
Weak
Solvency 35+35
equity 10.2% of total assets
Liquidity 49+25
short-term debt 29.9% · cash 9.5%
Profitability 0=
return on assets -25.0%
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (83 companies, NACE 47, large)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025lowest value 03-2025: 0.8%● unchanged vs 02-2025lowest value 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 1.0%▲ +0.2 percentage points vs 04-2025 06-2025: 1.0%● unchanged vs 05-2025 07-2025: 1.1%▲ +0.1 percentage points vs 06-2025 08-2025: 5.4%▲ +4.3 percentage points vs 07-2025 09-2025: 5.5%▲ +0.1 percentage points vs 08-2025 10-2025: 5.5%● unchanged vs 09-2025 11-2025: 5.5%● unchanged vs 10-2025 12-2025: 5.5%● unchanged vs 11-2025 01-2026: 5.5%● unchanged vs 12-2025 02-2026: 5.5%● unchanged vs 01-2026 03-2026: 5.5%● unchanged vs 02-2026 04-2026: 5.5%● unchanged vs 03-2026highest value 05-2026: 4.7%▼ -0.8 percentage points vs 04-2026 06-2026: 4.8%▲ +0.1 percentage points vs 05-2026 07-2026: 4.8%● unchanged vs 06-2026 08-2026: 1.2%▼ -3.6 percentage points vs 07-2026 09-2026: 1.2%● unchanged vs 08-2026 10-2026: 1.2%● unchanged vs 09-2026
Credit of up to €500,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.24, compared with 1.04 in 2024, above the usual 1.5; short-term debt: 29.9% and cash: 9.5% of total assets), but 89.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, large): better than 17% on solvency, 81% on liquidity, 3% on profitability and 86% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Loss of €19.3m, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Equity €7.9m (10.2% of total assets)
NBB · annual accounts
lowers risk · Size: turnover €87.4m, 541.6 FTE, total assets €77.2m, files consolidated accounts
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 4937 sector peers (2025).
NBB · sector comparison
Position among 4937 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
29 days early
2024
17 days early
2023
34 days early
2022
20 days early
2021
16 days early
2020
12 days early
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 20 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
15-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointment: Deloitte Bedrijfsrevisoren (statutory auditor)Permanent representative: Werner Van Gansbeke…
  2. Annual accounts filedfinancial year 2025 · full…
  3. Annual accounts filedfinancial year 2025 · unclassified…

Key points

  • Risk: 7 loss-making years in a rowloss financial year 2025 -€19.3m View
  • Caution: Among the weakest 5% on net resultsector median €40,683 · 4,937 companies -€19.3m View
  • 3 restructurings since 2023latest: merger with Goed Farma 3 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Flemish supportawarded from 2022 to 2025 €1.2m View

By topic

Financials

Financial year
2025
Turnover
€87.4m
Loss
-€19.3m
Solvency
10.2%
Turnover▲ 5.4%
Net result
20182025
Go to Financials

Board & ownership

Board
11 members
Auditor
Deloitte Bedrijfsrevisoren
  • DEPRINCEDirector
  • Bart De RuysscherDirector
  • Drieghe MarkDirector
  • Pierre RyceckDirector
  • Steven HermansDirector

and 6 other directors

Go to Board & ownership

Network & group

Subsidiaries
1
Holdings
2
Connected companies
65
Mergers and asset contributions
15

2 holdings

Go to Network & group

Timeline

Events
81
Since
2003
Next accounts
by 31-07-2027
  1. 09-06-2026Permanent representative: Werner VAN GANSBEKE
  2. 31-12-2025Liquidity more than doubled
  3. 31-12-2025Equity above €5m
Go to Timeline

Company details

Sites
38
Legal form
Cooperative company
Activity
Retail sale of medical and orthopaedic goods, excluding…NACE 47741
Founded
18-09-2003
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
6
Purpose
“Distributie van hulpmiddelen via thuiszorgwinkels en hoorcentra; Gespecialiseerd advies…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.